Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Oxytrol For Women Exclusivity Ends Not With Competition, But Label Warning Change

14 Mar 2016

Related Content

<em>Alli </em>Return In U.S. Fattens Glaxo’s Consumer Outlook

25 Feb 2015

Perrigo's 'Inversion' Of <em>Flonase</em> Trademark Cuts Too Close For Glaxo's Market Share Comfort

04 Mar 2016

Oxytrol OTC Success Depends On Driving Behavioral Changes

25 Oct 2013

Related Companies

Perrigo Company PLC

Allergan plc

Merck & Co., Inc.

Bayer AG

GSK plc

Sanofi

Johnson & Johnson

AstraZeneca PLC

Allergan plc

Warner Chilcott PLC

Pfizer Inc.

Additional Topics

Dietary Supplements

More from Archive

More from HBW Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.